Icon
+91 94997 68112
Login Register

BYETTA (nda021773)- (300MCG/1.2ML (250MCG/ML),600MCG/2.4ML (250MCG/ML))

EXENATIDE SYNTHETIC ASTRAZENECA AB
300MCG/1.2ML (250MCG/ML),600MCG/2.4ML (250MCG/ML)
Yes No
2020-Jan-14 Expired
None None
None No
BYETTA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
0 0 0
Total Other Developers 2
Drugs with Suitability No
300MCG/1.2ML (250MCG/ML) ** ** Up - -
600MCG/2.4ML (250MCG/ML) ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report

Download GenUS Detailed Report

To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.